| Drug Type Peptide drug conjugates | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism MMP14 inhibitors(Matrix metalloproteinase 14 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 


| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | United Kingdom  | 11 Apr 2022 | 





